Evidence map›Paper›PMID 26820158›Full record

Trial reportEuropean journal of applied physiology2016

Increased endothelial microparticles and oxidative stress at extreme altitude.

Jacqueline Pichler Hefti, Alexander Leichtle, Monika Stutz, Urs Hefti, Thomas Geiser, Andreas R Huber, Tobias M Merz

Open access · greenAbstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in European journal of applied physiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Increased Circulating CD62EStem cell reviews and reports · 2023
    Article
  9. Article
  10. Review
  11. Article
  12. [Betelnut polyphenols provide protection against high-altitude hypoxia in rats].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2021
    Article
  13. Article
  14. Characteristics of Cerebral Stroke in the Tibet Autonomous Region of China.Medical science monitor : international medical journal of experimental and clinical research · 2020
    Article
  15. Article
  16. Article
  17. Observational
  18. Endothelial microvesicles in hypoxic hypoxia diseases.Journal of cellular and molecular medicine · 2018
    Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Jacqueline Pichler HeftiDepartment of Pneumology, University Hospital and University of Bern, Bern, Switzerland. Jacqueline.Pichler@Insel.ch.
Alexander LeichtleUniversity Institute of Clinical Chemistry, University Hospital and University of Bern, Bern, Switzerland.
Monika StutzDepartment of Clinical Investigation, University Hospital and University of Bern, Bern, Switzerland.
Urs HeftiSwiss Sportsclinic, Bern, Switzerland.
Thomas GeiserDepartment of Pneumology, University Hospital and University of Bern, Bern, Switzerland.
Andreas R HuberCenter of Laboratory Medicine, Cantonal Hospital Aarau, Aarau, Switzerland.
Tobias M MerzDepartment of Intensive Care Medicine, University Hospital and University of Bern, Bern, Switzerland.
University of Bern · CHKantonsspital Aarau · CHSwiss Cancer League · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeHypoxia and oxidative stress affect endothelial function. Endothelial microparticles (MP) are established measures of endothelial dysfunction and influence vascular reactivity. To evaluate the effects of hypoxia and antioxidant supplementation on endothelial MP profiles, a double-blind, placebo-controlled trial, during a high altitude expedition was performed.

methods29 participants were randomly assigned to a treatment group (n = 14), receiving vitamin E, C, A, and N-acetylcysteine daily, and a control group (n = 15), receiving placebo. Blood samples were obtained at 490 m (baseline), 3530, 4590, and 6210 m. A sensitive tandem mass spectrometry method was used to measure 8-iso-prostaglandin F2α and hydroxyoctadecadienoic acids as markers of oxidative stress. Assessment of MP profiles including endothelial activation markers (CD62+MP and CD144+MP) and cell apoptosis markers (phosphatidylserine+MP and CD31+MP) was performed using a standardized flow cytometry-based protocol.

results15 subjects reached all altitudes and were included in the final analysis. Oxidative stress increased significantly at altitude. No statistically significant changes were observed comparing baseline to altitude measurements of phosphatidylserine expressing MP (p = 0.1718) and CD31+MP (p = 0.1305). Compared to baseline measurements, a significant increase in CD62+MP (p = 0.0079) and of CD144+MP was detected (p = 0.0315) at high altitudes. No significant difference in any MP level or oxidative stress markers were found between the treatment and the control group.

conclusionHypobaric hypoxia is associated with increased oxidative stress and induces a significant increase in CD62+ and CD144+MP, whereas phosphatidylserine+MP and CD31+MP remain unchanged. This indicates that endothelial activation rather than an apoptosis is the primary factor of hypoxia induced endothelial dysfunction.

Indexed as

AltitudeOxidative StressAcetylcysteineAdultAntioxidantsApoptosisBiomarkersCell-Derived MicroparticlesDouble-Blind MethodEndothelium, VascularFemaleHumansHypoxiaMaleMiddle AgedProstaglandinsAcetylcysteineAntioxidantsBiomarkersProstaglandinsVitaminsEndothelial dysfunctionExtreme altitudeHypoxiaMicroparticlesOxidative stress

Identifiers

PMID26820158
OpenAlexW2292565922

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.